Get Integrated Data for Your Specialty and Interest Aresa
 
Category Select :
Items 141 ~ 160 of 25816, Page 8 of 1292
141. Medtronic Completes Acquisition of Mazor Robotics - 12/19/2018
 Medtronic
  Company Integrates Robotics and Aims to Make Spine Surgery More Predictable and Transform Outcomes for Hospitals, Surgeons, and Patients
142. FDA Approves Mercks KEYTRUDA (pembrolizumab) for the Treatment of Adult and Pediatric Patients with Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma, a Rare Form of Skin Cancer - 12/19/2018
 MERCK
  Accelerated Approval Based on Results of CITN-09/KEYNOTE-017, Where KEYTRUDA Monotherapy Demonstrated an Objective Response Rate of 56 percent
143. Get Bubbly this New Year with Abbott''s New Pedialyte Sparkling Rush Powder Packs - 12/19/2018
 Abbott
  Pedialyte Sparkling Rush is advanced rehydration with a fizz, with an optimal balance of electrolytes and carbohydrate to prevent mild to moderate dehydration
144. Statement from FDA Commissioner Scott Gottlieb, M.D. on the FDAs 2017 report on declining sales/distribution of antimicrobial drugs for food animals, a reflection of improved antimicrobial stewardship - 12/18/2018
 U.S. FOOD & DRUG ADMINISTRATION
145. Statement from FDA Commissioner Scott Gottlieb, M.D., and Jeff Shuren, M.D., Director of the Center for Devices and Radiological Health, on new steps to promote innovations in medical devices that help advance patient safety - 12/18/2018
 U.S. FOOD & DRUG ADMINISTRATION
146. MRI Effective for Monitoring Liver Fat in Obese Patients - 12/18/2018
 Radiological Society of North America
  Liver fat in 50 patients was assessed before and after bariatric surgery using chemical shift-encoded MRI (CSE-MRI), a safe and noninvasive technique.
147. FDA Approves Smart Programmer for the InterStim System - 12/17/2018
 Medtronic
  Intuitive and Discreet Device Provides Sacral Neuromodulation Therapy for Overactive Bladder and Bowel Incontinence
148. European Commission Approves Mercks KEYTRUDA (pembrolizumab) as Adjuvant Therapy for Adults with Resected Stage III Melanoma - 12/17/2018
 MERCK
  European Approval Based on Significant Recurrence-Free Survival Benefit Demonstrated with KEYTRUDA in the Pivotal Phase 3 EORTC1325/KEYNOTE-054 Trial / First Approval for KEYTRUDA in an Adjuvant Setting in the European Union
149. Michigan-based food manufacturer agrees to stop operations after repeated food safety violations - 12/17/2018
 U.S. FOOD & DRUG ADMINISTRATION
150. 1 in 4 Nonsmoking Americans is Still Exposed to Secondhand Smoke - 12/17/2018
 American Cancer Society
  After 2 decades of progress, efforts to reduce exposure to secondhand smoke among non-smokers have stalled in the US, according to new data from the Centers for Disease Control and Prevention (CDC).
151. Abbott Hosts Conference Call for Fourth-Quarter Earnings - 12/17/2018
 Abbott
  ABBOTT PARK, Ill., Dec. 17, 2018 /PRNewswire/ --?Abbott (NYSE: ABT)?will announce its fourth-quarter 2018 financial results on Wednesday, Jan. 23, 2019, before the market opens.
152. Merck to Acquire Privately Held Antelliq Group - 12/14/2018
 MERCK
  Establishes Merck Animal Health as a Leader in Emerging Digital Tracking, Traceability and Monitoring Technology / Complements Merck Animal Health Portfolio of Vaccines and Pharmaceuticals
153. Abbott Raises Quarterly Dividend 14%, Increasing Payouts for 47 Straight Years - 12/14/2018
 Abbott
  The board of directors of Abbott (NYSE: ABT) today increased the company''''s quarterly common dividend to 32 cents per share, marking a 14 percent increase.
154. 3-Time Cancer Survivor Finds Comfort at Hope Lodge - 12/14/2018
 American Cancer Society
  Cervical and breast cancer survivor Christine E. Sprecher needed treatment for a long-term side effect but had no place to stay until she found the American Cancer Society Hope Lodge program.
155. Statement from FDA Commissioner Scott Gottlieb, M.D. and Director of FDAs Center for Drug Evaluation and Research Janet Woodcock, M.D., on efforts to modernize generic drug labels while maintaining the efficiency of generic development - 12/13/2018
 U.S. FOOD & DRUG ADMINISTRATION
156. Nearly 30 million sick and premature newborns in dire need of treatment every year - 12/13/2018
 WHO
  Global coalition calls for better care and stronger legislation to save babies on the brink of death
157. Enjoy the icy slopes and sidestep injuries - 12/13/2018
 American Academy of Orthopaedic Surgeons
  Orthopaedic surgeons offer safety tips to avoid injuries this winter
158. Make Sure Protective Eyewear is on Your Christmas Shopping List - 12/13/2018
 American Academy of Ophthalmology
  New study from the American Academy of Ophthalmology describes blinding eye injuries caused by BB guns.
159. Statement from FDA Commissioner Scott Gottlieb, M.D., on the agencys efforts to improve drug quality through vigilant oversight of data integrity and good manufacturing practice - 12/12/2018
 U.S. FOOD & DRUG ADMINISTRATION
160. Merck and Instituto Butantan Announce Collaboration Agreement to Develop Vaccines to Protect Against Dengue Infections - 12/12/2018
 MERCK
<<  <  [1]  [2]  [3]  [4]  [5]  [6]  [7]  [8[9]  [10]  >  >>
 


Copyright ~2018 by Medisurf. All Rights Reserved Terms of Service Privacy Email : medalls@medalls.com